Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure: a clinical review

DRB de Virginy - Heart Failure Reviews, 2006 - Springer
Over the last two decades, the pathophysiology and biomolecular basis of heart failure
syndrome has reached sound and more comprehensive understanding. This knowledge …

Síndrome coronario agudo: Marcadores de lesión miocárdica

JRB Evia - Revista Mexicana de Patología Clínica y Medicina de …, 2007 - medigraphic.com
Hoy en día, la enfermedad cardiovascular (ECV) representa uno de los principales
problemas de salud pública a nivel mundial, por lo tanto es necesario contar con una serie …

Improvement of the cardiac marker N-terminal-pro brain natriuretic peptide through adjustment for renal function: a stratified multicenter trial

A Luchner, A Weidemann, R Willenbrock… - Clinical chemistry and …, 2010 - degruyter.com
Background: N-terminal-pro brain natriuretic peptide (NT-proBNP) is a useful cardiac marker
that is also influenced by renal dysfunction. It was our objective to assess the relationship …

Association of N-terminal pro-brain natriuretic peptide with the severity of coronary artery disease in patients with normal left ventricular ejection fraction

N Wu, F Ma, Y Guo, X Li, J Liu, P Qing, R Xu… - Chinese Medical …, 2014 - journals.lww.com
Methods A total of 658 consecutive patients were divided into two groups based on
angiograms: CAD group (n= 484) and angiographic normal control group (n= 174). The …

Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction

B Waldum, V Stubnova, AS Westheim… - Clinical kidney …, 2013 - academic.oup.com
Background Renal dysfunction is considered a confounding variable in the interpretation of
B-type natriuretic peptides (BNPs) and their amino-terminal fragments (NT-ProBNP) in …

[引用][C] 脑钠肽与心血管疾病

杨萍, 田青 - 心血管病学进展, 2008

Comprehensive review of the relative clinical utility of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide assays in cardiovascular disease

PA McCullough, A Neyou - Open Heart Failure Journal, 2009 - benthamopen.com
Measurable B-type natriuretic peptides, which are largely produced by the left ventricle,
include B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NT …

[HTML][HTML] Serial measurements of N-terminal pro-brain natriuretic peptide in patients with coronary heart disease

D Dallmeier, MJ Pencina, I Rajman, W Koenig… - PLoS …, 2015 - journals.plos.org
Objective To assess the prognostic value of 12-months N-Terminal Pro-Brain Natriuretic
Peptide (NT-proBNP) levels on adverse cardiovascular events in patients with stable …

[HTML][HTML] Предоперационный уровень натрийуретических пептидов В-типа и результаты клинико-функционального обследования кардиохирургических …

ИА Козлов, ИЕ Харламова… - Общая …, 2009 - cyberleninka.ru
Цель исследования изучить содержание натрийуретических пептидов В-типа в плазме
больных ишемической болезнью сердца, подготовленных к операции с искусственным …

Monitoring the response to pharmacologic therapy in patients with stable chronic heart failure: is BNP or NT-proBNP a useful assessment tool?

CM Balion, RS McKelvie, S Reichert, P Santaguida… - Clinical …, 2008 - Elsevier
Objectives: B-type natriuretic peptides are biomarkers of heart failure (HF) that can decrease
following treatment. We sought to determine whether B-type natriuretic peptide (BNP) or N …